Tema Neuroscience And Mental Health Etf (MNTL)

Jul 25, 2024

Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says - CNBC

Jul 25, 2024

Jul 18, 2024

Where to Invest in Health Trends - Bloomberg

Jul 18, 2024

May 23, 2024

Tema ETFs CIO on Investment Opportunities in Biotech - Opto RoW

May 23, 2024

May 08, 2024

Vertex's Pain Drug Could Be Worth Up To $11.4 Billion — Ongoing Debate Sparks Shares - MSN

May 08, 2024

May 07, 2024

Vertex Stock Sparks As Debate Rages Over Potential Blockbuster Pain Drug - Investor's Business Daily

May 07, 2024

May 06, 2024

Vertex shares flat on repeat guidance despite first-quarter gainsTHE BHARAT EXPRESS NEWS - The Bharat Express News

May 06, 2024

Apr 24, 2024

Biogen cost cuts drive profit beat, as Alzheimer's drug off to slow start - Yahoo Finance

Apr 24, 2024

Apr 08, 2024

Healthcare ETFs for the Weight-Loss Drug Boom & Beyond - Yahoo Finance

Apr 08, 2024

Mar 19, 2024

Benzinga's 2024 Virtual Healthcare Summit: What's Next In Health? - Benzinga

Mar 19, 2024

Feb 19, 2024

'This is the mental health moment': Innovation and M&A are helping to boost these stocks to new heights - CNBC

Feb 19, 2024

Feb 16, 2024

Introducing the Tema Neuroscience and Mental Health ETF (MNTL) - NEWS CHANNEL NEBRASKA

Feb 16, 2024

Feb 13, 2024

Introducing the Tema Neuroscience and Mental Health ETF (MNTL), Business Wires News - AsiaOne

Feb 13, 2024

Jan 26, 2024

This Week in ETFs: Closures Outnumber New ETFs - ETF Trends

Jan 26, 2024

Jan 25, 2024

US ETF launches from 18th to 25th January, 2024 - ETF Express

Jan 25, 2024

Jun 19, 2021

Best Stocks Under $50 Right Now - Benzinga

Jun 19, 2021